ResoTher Pharma A/S — Credit Rating and Financial Key Figures

ResoTher Pharma A/S (CVR number: 37852406K) is a company from RUDERSDAL. The company recorded a gross profit of 0 kDKK in 2023. The operating profit was -19.9 mDKK, while net earnings were -17.5 mDKK. The profitability of the company measured by Return on Assets (ROA) was -100.3 %, which can be considered poor and Return on Equity (ROE) was -101.3 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 95.4 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. ResoTher Pharma A/S's liquidity measured by quick ratio was 21.7 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.